| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T23 |
0-12 |
Sentence |
denotes |
Introduction |
| T24 |
13-161 |
Sentence |
denotes |
In six months, the number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases exceeded six million, with more than 360,000 deaths. |
| T25 |
162-448 |
Sentence |
denotes |
The World Health Organization named the disease the coronavirus disease 2019 (COVID-19) and declared it a pandemic on 11 March 2020.1 Although the lung is the primary affected organ, the virus is neurovirulent and neuroinvasive with a growing recognition of neurological manifestations. |
| T26 |
449-840 |
Sentence |
denotes |
The reported incidence of stroke in COVID-19 hospitalized patients is 0.9–2%,2,3 with an increased incidence in the young.4 More important than the increased incidence, is the poor outcome and high mortality rate, even with optimal treatment.5,6 A recent cross-sectional comparative study from New York identified a 7.5-fold higher rate of ischemic stroke in COVID-19 compared to influenza.3 |
| T27 |
841-1102 |
Sentence |
denotes |
In the current pandemic situation, a better understanding of the pathophysiological mechanisms associated with COVID-19 and characterization of cerebrovascular pathologies and outcomes is critical not only to estimate the risk but also to guide decision making. |
| T28 |
1103-1233 |
Sentence |
denotes |
We present a case series of COVID-19 patients from two different health systems presenting with acute cerebrovascular pathologies. |
| T29 |
1234-1394 |
Sentence |
denotes |
We also reviewed the literature to present a comprehensive summary of the SARS-CoV-2-induced factors that are associated with acute cerebrovascular pathologies. |
| T30 |
1395-1518 |
Sentence |
denotes |
In addition, we performed a pooled analysis of published data on large vessel occlusion strokes in the setting of COVID-19. |
